ESC 365 - Prognostic impact of sarcopenia on major adverse cardiovascular outcomes in coronary artery disease patients undergoing successful percutaneous coronary intervention

ESC Premium Access

Prognostic impact of sarcopenia on major adverse cardiovascular outcomes in coronary artery disease patients undergoing successful percutaneous coronary intervention

Session: Assessment of residual risk after percutaneous coronary intervention

Topic: Comorbidities

Speaker: Associate Professor D. Kang (Seoul, KR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Dong Oh Kang

Korea University Guro Hospital, Seoul (Korea (Republic of))

0 follower

4 more presentations in this session

Validation of quantitative flow reserve and residual quantitative flow reserve to predict fractional flow reserve post stenting from the DOCTORS study population

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)

Percutaneous coronary intervention versus medical therapy for coronary lesions with positive fractional flow reserve (FFR) but preserved coronary flow reserve (CFR). A substudy of the COMPARE-ACUTE

Speaker: Doctor J. Haeck (Leeuwarden, NL)

Diagnostic performance of quantitative flow ratio from coronary angiography versus fractional flow reserve from computed tomography

Speaker: Doctor H. Emori (Wakayama, JP)

Long-term risk stratification of patients undergoing coronary angiography according to the TIMI risk score for secondary prevention

Speaker: Doctor B. Zafrir (Haifa, IL)

Access the full session

Assessment of residual risk after percutaneous coronary intervention

Speakers: Associate Professor D. Kang, Doctor J. Adjedj, Doctor J. Haeck, Doctor H. Emori, Doctor B. Zafrir

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources